Profile | GDS5420 / 228643_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 132.85 | 46 |
GSM1296119 | B_lesional_pre-dose | 117.78 | 43 |
GSM1296076 | C_lesional_pre-dose | 84.61 | 40 |
GSM1296092 | D_lesional_pre-dose | 69.22 | 38 |
GSM1296103 | E_lesional_pre-dose | 65.24 | 35 |
GSM1296078 | F_lesional_pre-dose | 46.17 | 30 |
GSM1296107 | G_lesional_pre-dose | 216.66 | 53 |
GSM1296109 | H_lesional_pre-dose | 180.78 | 49 |
GSM1296080 | I_lesional_pre-dose | 40.82 | 29 |
GSM1296090 | J_lesional_pre-dose | 78.72 | 39 |
GSM1296074 | K_lesional_pre-dose | 93.75 | 43 |
GSM1296111 | L_lesional_pre-dose | 155.56 | 47 |
GSM1296099 | M_lesional_pre-dose | 62.24 | 34 |
GSM1296086 | O_lesional_pre-dose | 96.49 | 42 |
GSM1296117 | P_lesional_pre-dose | 259.04 | 56 |
GSM1296113 | Q_lesional_pre-dose | 300.74 | 58 |
GSM1296096 | R_lesional_pre-dose | 85.16 | 40 |
GSM1296105 | S_lesional_pre-dose | 65.15 | 34 |
GSM1296098 | T_lesional_pre-dose | 171.31 | 49 |
GSM1296101 | U_lesional_pre-dose | 109.65 | 42 |
GSM1296121 | V_lesional_pre-dose | 155.7 | 48 |
GSM1296088 | W_lesional_pre-dose | 38.58 | 28 |
GSM1296082 | X_lesional_pre-dose | 64.36 | 36 |
GSM1296115 | Y_lesional_pre-dose | 203.42 | 52 |
GSM1296084 | Z_lesional_pre-dose | 90.89 | 40 |
GSM1296072 | B_lesional_day8 | 165.6 | 48 |
GSM1296069 | L_lesional_day8 | 230.15 | 53 |
GSM1296071 | P_lesional_day8 | 207.01 | 51 |
GSM1296070 | Y_lesional_day8 | 177.15 | 48 |
GSM1296073 | V_lesional_day8 | 188.03 | 52 |
GSM1296034 | A_lesional_day15 | 79.5 | 37 |
GSM1296041 | G_lesional_day15 | 252.24 | 56 |
GSM1296035 | R_lesional_day15 | 94.09 | 41 |
GSM1296038 | U_lesional_day15 | 83.59 | 39 |
GSM1296047 | B_lesional_day15 | 192.52 | 51 |
GSM1296039 | E_lesional_day15 | 73.98 | 37 |
GSM1296042 | H_lesional_day15 | 240.27 | 54 |
GSM1296043 | L_lesional_day15 | 157.77 | 46 |
GSM1296037 | M_lesional_day15 | 124.67 | 44 |
GSM1296046 | P_lesional_day15 | 290.35 | 57 |
GSM1296044 | Q_lesional_day15 | 426.18 | 64 |
GSM1296045 | Y_lesional_day15 | 217.65 | 52 |
GSM1296025 | C_lesional_day15 | 94.69 | 41 |
GSM1296033 | D_lesional_day15 | 104.9 | 43 |
GSM1296027 | I_lesional_day15 | 79.81 | 40 |
GSM1296032 | J_lesional_day15 | 62.26 | 34 |
GSM1296024 | K_lesional_day15 | 73.03 | 38 |
GSM1296031 | W_lesional_day15 | 99.88 | 40 |
GSM1296028 | X_lesional_day15 | 124.66 | 45 |
GSM1296029 | Z_lesional_day15 | 99.57 | 42 |
GSM1296026 | F_lesional_day15 | 44.15 | 29 |
GSM1296030 | O_lesional_day15 | 86.05 | 42 |
GSM1296040 | S_lesional_day15 | 49.98 | 30 |
GSM1296036 | T_lesional_day15 | 274.62 | 57 |
GSM1296048 | V_lesional_day15 | 120.5 | 43 |
GSM1296059 | A_lesional_day43 | 49.49 | 32 |
GSM1296066 | G_lesional_day43 | 303.03 | 59 |
GSM1296060 | R_lesional_day43 | 62.54 | 35 |
GSM1296063 | U_lesional_day43 | 127.11 | 45 |
GSM1296064 | E_lesional_day43 | 142.94 | 48 |
GSM1296067 | H_lesional_day43 | 177.41 | 48 |
GSM1296062 | M_lesional_day43 | 94.68 | 40 |
GSM1296068 | Q_lesional_day43 | 346.65 | 60 |
GSM1296050 | C_lesional_day43 | 97.42 | 41 |
GSM1296057 | D_lesional_day43 | 66.99 | 36 |
GSM1296052 | I_lesional_day43 | 78.21 | 40 |
GSM1296054 | J_lesional_day43 | 124.71 | 44 |
GSM1296049 | K_lesional_day43 | 84.41 | 39 |
GSM1296055 | W_lesional_day43 | 46.21 | 29 |
GSM1296053 | X_lesional_day43 | 67.51 | 36 |
GSM1296058 | Z_lesional_day43 | 60.79 | 35 |
GSM1296051 | F_lesional_day43 | 66.81 | 36 |
GSM1296056 | O_lesional_day43 | 78.33 | 39 |
GSM1296065 | S_lesional_day43 | 84.09 | 38 |
GSM1296061 | T_lesional_day43 | 131.43 | 45 |
GSM1296095 | A_non-lesional_pre-dose | 118.88 | 45 |
GSM1296120 | B_non-lesional_pre-dose | 188.57 | 50 |
GSM1296077 | C_non-lesional_pre-dose | 121.18 | 45 |
GSM1296093 | D_non-lesional_pre-dose | 80.7 | 37 |
GSM1296104 | E_non-lesional_pre-dose | 87.18 | 39 |
GSM1296079 | F_non-lesional_pre-dose | 45.34 | 29 |
GSM1296108 | G_non-lesional_pre-dose | 178.98 | 50 |
GSM1296110 | H_non-lesional_pre-dose | 222.81 | 52 |
GSM1296081 | I_non-lesional_pre-dose | 46.26 | 32 |
GSM1296091 | J_non-lesional_pre-dose | 57.13 | 34 |
GSM1296075 | K_non-lesional_pre-dose | 105.94 | 43 |
GSM1296112 | L_non-lesional_pre-dose | 218.8 | 52 |
GSM1296100 | M_non-lesional_pre-dose | 71.41 | 36 |
GSM1296087 | O_non-lesional_pre-dose | 134.15 | 48 |
GSM1296118 | P_non-lesional_pre-dose | 324.12 | 59 |
GSM1296114 | Q_non-lesional_pre-dose | 464.09 | 66 |
GSM1296097 | R_non-lesional_pre-dose | 75.04 | 37 |
GSM1296106 | S_non-lesional_pre-dose | 85.06 | 37 |
GSM1296102 | U_non-lesional_pre-dose | 121.94 | 43 |
GSM1296122 | V_non-lesional_pre-dose | 209.73 | 52 |
GSM1296089 | W_non-lesional_pre-dose | 105.13 | 41 |
GSM1296083 | X_non-lesional_pre-dose | 35.84 | 27 |
GSM1296116 | Y_non-lesional_pre-dose | 210.47 | 51 |
GSM1296085 | Z_non-lesional_pre-dose | 137.44 | 46 |